The first in an ongoing series of Consumer Advocacy Discussion Forums for men and families facing prostate cancer.
The Australian Government is currently reviewing the National Medicines Policy (NMP). The outcomes will have major implications for Australian men and families living with prostate cancer, creating a policy framework that will help to define survivorship care.
The overarching aim of the review is to deliver positive health outcomes for all Australians, through accessible and appropriate use of medicines.
A lot has changed since the policy was created in 2000 – living standards have improved, consumer expectations have increased, technology has advanced, and research has delivered an array of new medicines and therapies with life-saving potential, if only men could access them equitably, affordably, and in a timely way.
The panel discussion was hosted by prostate cancer survivor and Nine News Presenter, Will McDonald, with an expert panel of speakers:
Professor Jeff Dunn AO: Chief of Mission & Head of Research / Prostate Cancer Foundation of Australia
President-Elect / Union for International Cancer Control
Mr Troels Wolthers: Executive Medical Director / Amgen Australia
Mr Ian Noble: Director Value Access and Policy / Amgen Australia
Adjunct Professor Sally Sara: Director of Nursing Programs / Prostate Cancer Foundation of Australia
